SEC Form 4
Labcorp Holdings Inc. (LH) insider trading
In the 12 months to Oct 26, 2026, 10 LH insiders reported open-market sales of $13.7M across 20 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $13.7M
- 20 filings · 10 insiders
- Open-market purchases
- $0
- 0 filings
- Pre-arranged sales (10b5-1)
- 14 of 20
- $8.2M of $13.7M sold (60%)
Who traded LH, and when
- Sale
- Sale, pre-arranged (10b5-1)
LH daily close from Oct 27, 2025 to Oct 26, 2026, between $246.64 and $339.34, last $328.28. 20 sale and 0 purchase filings by 10 insiders, marked at their filing dates. Adam H. Schechter, President & CEO: sold $8.4M across 5 filings, first filed Nov 13, 2025, last Aug 12, 2026. Richelle P. Parham, Director: sold $1.8M across 1 filing, first filed Nov 4, 2025, last Nov 4, 2025. Peter J. Wilkinson, SVP, Chief Accounting Officer: sold $1.1M across 3 filings, first filed Feb 23, 2026, last Aug 5, 2026. Kerrii B. Anderson, Director: sold $954.1K across 1 filing, first filed Aug 18, 2026, last Aug 18, 2026. Brian J. Caveney, EVP, Pres of ED, CMO & CSO: sold $429.5K across 1 filing, first filed Feb 26, 2026, last Feb 26, 2026. Jonathan C. Meltzer, EVP, Operations: sold $298.8K across 4 filings, first filed Feb 10, 2026, last Mar 30, 2026. 4 others: sold $733.8K across 5 filings, first filed Mar 3, 2026, last Aug 6, 2026.
Largest mark · tap a row for others
Adam H. Schechter · President & CEO
Sale $2,437,047
8,705 shares at $279.96 avg
Filed Mar 5, 2026 · traded Mar 3
Close on filing date $275.92
Adam H. Schechter · President & CEO
President & CEO
$8.4M soldRichelle P. Parham · Director
Director
$1.8M soldPeter J. Wilkinson · SVP, Chief Accounting Officer
SVP, Chief Accounting Officer
$1.1M soldKerrii B. Anderson · Director
Director
$954.1K soldBrian J. Caveney · EVP, Pres of ED, CMO & CSO
EVP, Pres of ED, CMO & CSO
$429.5K soldJonathan C. Meltzer · EVP, Operations
EVP, Operations
$298.8K sold4 others
Combined, one mark per week
$733.8K soldOpen-market trades
20 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Adam H. Schechter | President & CEO | $8.4M | — | 5 | 71% of sales | |
| Richelle P. Parham | Director | $1.8M | — | 1 | — | |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | $1.1M | — | 3 | 59% of sales | |
| Kerrii B. Anderson | Director | $954.1K | — | 1 | 100% of sales | |
| Brian J. Caveney | EVP, Pres of ED, CMO & CSO | $429.5K | — | 1 | — | |
| Jonathan C. Meltzer | EVP, Operations | $298.8K | — | 4 | 100% of sales | |
| Amy B. Summy | EVP, Chief Marketing Officer | $283.4K | — | 1 | — | |
| Kathryn W. Kyle | EVP, Chief Legal Officer | $227.4K | — | 2 | 100% of sales | |
| van der Vaart Sandra D | EVP, Corporate Affairs | $156.0K | — | 1 | — | |
| Bryan T. Vaughn | EVP and President, Diagnostics | $67.0K | — | 1 | 100% of sales |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Kerrii B. Anderson Director | SalePre-arranged (10b5-1) | 3,000 | $318.02 | $954.1K | 6,563 | |
traded | Adam H. Schechter President & CEO | SalePre-arranged (10b5-1) | 4,669 | $320.37 | $1.5M | 102,565 | |
traded | Amy B. Summy EVP, Chief Marketing Officer | Sale | 924 | $306.74 | $283.4K | 6,956 | |
traded | Peter J. Wilkinson SVP, Chief Accounting Officer | Sale | 1,420 | $309.23 | $439.1K | 1,770 | |
traded | Bryan T. Vaughn EVP and President, Diagnostics | SalePre-arranged (10b5-1) | 234 | $286.19 | $67.0K | 6,746 | |
traded | Kathryn W. Kyle EVP, Chief Legal Officer | SalePre-arranged (10b5-1) | 92 | $286.19 | $26.3K | 3,904 | |
traded | Kathryn W. Kyle EVP, Chief Legal Officer | SalePre-arranged (10b5-1) | 762 | $263.89 | $201.1K | 3,813 | |
traded | Adam H. Schechter President & CEO | SalePre-arranged (10b5-1) | 5,903 | $254.50 | $1.5M | 107,234 | |
traded | Jonathan C. Meltzer EVP, Operations | SalePre-arranged (10b5-1) | 839 | $267.05 | $224.1K | 3,620 | |
traded | Peter J. Wilkinson SVP, Chief Accounting Officer | SalePre-arranged (10b5-1) | 1,633 | $267.05 | $436.1K | 1,852 | |
traded | Adam H. Schechter President & CEO | Sale | 8,705 | $279.96 | $2.4M | 80,773 | |
traded | van der Vaart Sandra D EVP, Corporate Affairs | Sale | 548 | $284.91 | $156.0K | 2,579 | |
traded | Brian J. Caveney EVP, Pres of ED, CMO & CSO | Sale | 1,500 | $286.31 | $429.5K | 30,107 | |
traded | Peter J. Wilkinson SVP, Chief Accounting Officer | SalePre-arranged (10b5-1) | 666 | $277.94 | $185.1K | 1,852 | |
traded | Jonathan C. Meltzer EVP, Operations | SalePre-arranged (10b5-1) | 87 | $290.42 | $25.3K | 2,782 | |
traded | Adam H. Schechter President & CEO | SalePre-arranged (10b5-1) | 5,273 | $284.38 | $1.5M | 87,343 | |
traded | Jonathan C. Meltzer EVP, Operations | SalePre-arranged (10b5-1) | 91 | $276.79 | $25.2K | 2,696 | |
traded | Jonathan C. Meltzer EVP, Operations | SalePre-arranged (10b5-1) | 88 | $275.53 | $24.2K | 2,869 | |
traded | Adam H. Schechter President & CEO | SalePre-arranged (10b5-1) | 5,745 | $262.75 | $1.5M | 87,574 | |
traded | Richelle P. Parham Director | Sale | 7,009 | $254.28 | $1.8M | 2,469 |
GET /stocks/filings/vX/form-4?tickers=LH&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"LH"
],
"issuer_cik": "0000920148",
"owner_cik": "0001227159",
"accession_number": "0000920148-26-000186",
"form_type": "4",
"filing_date": "2026-08-18",
"period_of_report": "2026-08-17",
"issuer_name": "LABCORP HOLDINGS INC.",
"issuer_trading_symbol": "LH",
"owner_name": "ANDERSON KERRII B",
"is_director": true,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-08-17",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 3000,
"transaction_price_per_share": 318.02,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 6563,
"transaction_value": 954060,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."
}
]
},
{
"tickers": [
"LH"
],
"issuer_cik": "0000920148",
"owner_cik": "0001376841",
"accession_number": "0000920148-26-000177",
"form_type": "4",
"filing_date": "2026-08-12",
"period_of_report": "2026-08-11",
"issuer_name": "LABCORP HOLDINGS INC.",
"issuer_trading_symbol": "LH",
"owner_name": "Schechter Adam H",
"is_director": true,
"is_officer": true,
"officer_title": "President & CEO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-08-11",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 4669,
"transaction_price_per_share": 320.37,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 102565,
"transaction_value": 1495807.53,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 129 records
- Option exercises55 records
- Tax withholding60 records
- Grants and awards14 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Labcorp Holdings Inc.'s CEO sold stock?
Yes. Adam H. Schechter (CEO) sold 30,295 shares ($8.4M) between Nov 2025 and Aug 2026, $6.0M of it under a pre-arranged 10b5-1 plan.
How current is LH’s insider data?
These are LH Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track LH insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for LH every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.